EPTIS
BAM Logo

Virus Genome Detection – Adenoviruses

[Virusgenom-Nachweis – Adenoviren]

EPTIS factsheet 159516 | Last revision 2017-11-03 | URL: https://www.eptis.bam.de/pts159516 https://www.eptis.bam.de/pts159516

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks Please fill in page 2 of the order form for handling of infectious samples for EQAS unless you already returned your completed form 2 to INSTAND e. V. when you registered for recent EQA schemes. Without your confirmation we cannot send you the EQAS samples. The INSTAND EQA schemes in virology are carried out in scientific cooperation with the Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV e.V.), Gesellschaft für Virologie (GfV e.V.) and Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM e.V.). Cooperation partners are: Joint Diagnostic Commission of DVV and GfV, Robert Koch-Institut, Paul-Ehrlich-Institut, Friedrich-Loeffler-Institut, Bernhard-Nocht-Institut, Reference Laboratories incl. National and International Reference Centers and National Consiliary Laboratories, Blood Transfusion Service of German Red Cross (DRK-Blutspendedienst Ost), World Health Organization and International Consortium for Blood Safety. The characterization of the EQA samples including the determination of the target values/consensus values is carried out in cooperation with the INSTAND Expert laboratories. Information for 2018 (for details please see www.instand-ev.de -> EQAS and EQAS Online) General remarks on the INSTAND EQA schemes in virus diagnostics: Please note that the samples of the respective EQA schemes are suitable to be analyzed by different methods for the detection of the corresponding analyte. Example: EQA scheme “Virus immunology - HIV-1 / HIV-2“ - The 4 samples of the sample set of the EQA scheme (335) can be analyzed on virus specific antibodies by different methods such as ELISA, ChLIA and other methods. The results of the respective method should be stated for all 4 samples of the sample set. The results reported for the different methods will be displayed in the participation documents (Individual results).
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Lyophilized cell culture-lysates Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for adenovirus DNA with the option for the determination of species and types, respectively -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 100 - 250
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

Operation is commissioned / requested by German Bundesärztekammer (General medical Council)
Fees and frequency
Participation fee 206 Euro
Regularly operated Yes (2 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Phone: +49-211-159213-0
Fax: +49-211-159213-30
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Wojtalewicz
Phone: +49-211-15921341
Fax: +49-211-15921330
Email: wojtalewicz@instand-ev.de wojtalewicz@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21